|
1
|
White HD and Chew DP: Acute myocardial
infarction. Lancet. 372:570–584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
O'Gara PT, Kushner FG, Ascheim DD, Casey
DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM,
Franklin BA, et al: 2013 ACCF/AHA guideline for the management of
ST-elevation myocardial infarction: A report of the American
College of Cardiology Foundation/American Heart Association Task
Force on Practice Guidelines. Circulation. 127:e362–e425.
2013.PubMed/NCBI
|
|
3
|
Fernández-Jiménez R, García-Prieto J,
Sánchez-González J, Agüero J, López-Martín GJ, Galán-Arriola C,
Molina-Iracheta A, Doohan R, Fuster V and Ibáñez B: Pathophysiology
underlying the bimodal edema phenomenon after myocardial
ischemia/reperfusion. J Am Coll Cardiol. 66:816–828. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bolli R, Becker L, Gross G, Mentzer R Jr,
Balshaw D and Lathrop DA: NHLBI Working Group on the Translation of
Therapies for Protecting the Heart from Ischemia: Myocardial
protection at a crossroads: The need for translation into clinical
therapy. Circ Res. 95:125–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cannon RO III: Mechanisms, management and
future directions for reperfusion injury after acute myocardial
infarction. Nat Clin Pract Cardiovasc Med. 2:88–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ibáñez B, Heusch G, Ovize M and Van de
Werf F: Evolving therapies for myocardial ischemia/reperfusion
injury. J Am Coll Cardiol. 65:1454–1471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
MacDonald R, Heiner J, Villarreal J and
Strote J: Loperamide dependence and abuse. BMJ Case Rep.
2015:bcr20152097052015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baker DE: Loperamide: A pharmacological
review. Rev Gastroenterol Disord. 7 Suppl 3:S11–S18.
2007.PubMed/NCBI
|
|
9
|
Kalgutkar AS and Nguyen HT: Identification
of an N-methyl-4-phenylpyridinium-like metabolite of the
antidiarrheal agent loperamide in human liver microsomes:
Underlying reason(s) for the lack of neurotoxicity despite the
bioactivation event. Drug Metab Dispos. 32:943–952. 2004.PubMed/NCBI
|
|
10
|
Wang XH, Zeng JF, Lin C and Chen SB:
Effects of morphine and sufentanil preconditioning against
myocardial ischemic-reperfusion injury in rabbits. Int J Clin Exp
Med. 8:15692–15699. 2015.PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu X, Sun C, Zheng D, Liu R, Wei X and Wu
Z: [The miR-21 attenuates hepatocyte hypoxia/reoxygenation injury
via inhibiting PTEN/PI3K/AKT signaling pathway]. Xi Bao Yu Fen Zi
Mian Yi Xue Za Zhi. 33:497–502. 2017.(In Chinese). PubMed/NCBI
|
|
18
|
Zhang Y, He S, Du X, Jiang Y, Tian B and
Xu S: Rapamycin suppresses hypoxia/reoxygenation-induced islet
injury by up-regulation of miR-21 via PI3K/Akt signalling pathway.
Cell Prolif. 50:2017. View Article : Google Scholar
|
|
19
|
Tee YT, Han CP, Ko JL, Chen GD, Yang SF,
Chen SC, Tsai HJ, Lin LY and Wang PH: Evaluation of matrix
metalloproteinase 2 expression in cervical carcinogenesis using
tissue array and integrated optical density for immunoreactivity.
Reprod Sci. 14:719–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32:(Database Issue). D277–D280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi M, Horton JD, Cohen JC, Hobbs HH and
Stephens RM: WholePathwayScope: A comprehensive pathway-based
analysis tool for high-throughput data. BMC Bioinformatics.
7:302006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Draghici S, Khatri P, Tarca AL, Amin K,
Done A, Voichita C, Georgescu C and Romero R: A systems biology
approach for pathway level analysis. Genome Res. 17:1537–1545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xia M, Huang R, Guo V, Southall N, Cho MH,
Inglese J, Austin CP and Nirenberg M: Identification of compounds
that potentiate CREB signaling as possible enhancers of long-term
memory. Proc Natl Acad Sci USA. 106:2412–2417. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brunzell DH, Mineur YS, Neve RL and
Picciotto MR: Nucleus accumbens CREB activity is necessary for
nicotine conditioned place preference. Neuropsychopharmacology.
34:1993–2001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cali JJ, Niles A, Valley MP, O'Brien MA,
Riss TL and Shultz J: Bioluminescent assays for ADMET. Expert Opin
Drug Metab Toxicol. 4:103–120. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carden DL and Granger DN: Pathophysiology
of ischaemia-reperfusion injury. J Pathol. 190:255–266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Caraceni P, VAN Thiel DH and Borle AB:
Time course of free radicals formation, lipid peroxidation, and
reoxygenation injury in perfused rat hepatocytes. Ann N Y Acad Sci.
723:356–359. 1994. View Article : Google Scholar
|
|
29
|
Burn BR and Varner KJ: Environmentally
persistent free radicals compromise left ventricular function
during ischemia/reperfusion injury. Am J Physiol Heart Circ
Physiol. 308:H998–H1006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang ZY, Li PJ, Chen TD, Yang L, Zhao JH,
Na T and Tang XQ: Protective effect and mechanism of morphine on
acute myocardial ischemia/reperfusion injury in rats. Zhongguo Wei
Zhong Bing Ji Jiu Yi Xue. 16:656–659. 2004.(In Chinese). PubMed/NCBI
|
|
31
|
Chang WL, Lee SS and Su MJ: Attenuation of
post-ischemia reperfusion injury by thaliporphine and morphine in
rat hearts. J Biomed Sci. 12:611–619. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen Z, Zhang X, Liu Y and Liu Z: Morphine
postconditioning protects against reperfusion injury via inhibiting
JNK/p38 MAPK and mitochondrial permeability transition pores
signaling pathways. Cell Physiol Biochem. 39:61–70. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mourouzis I, Saranteas T, Perimenis P,
Tesseromatis C, Kostopanagiotou G, Pantos C and Cokkinos DV:
Morphine administration at reperfusion fails to improve
postischaemic cardiac function but limits myocardial injury
probably via heat-shock protein 27 phosphorylation. Eur J
Anaesthesiol. 26:572–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ran K, Gong ZX, Yang DL, Chang YT, Duan KM
and Ou YW: Effect of morphine preconditioning in the delayed phase
on the expression of p38 mitogen-activated protein kinase in a
rabbit model of myocardial ischemia-reperfusion injury. Genet Mol
Res. 14:6642–6648. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Y, Zhu W, Wang Z, Yuan W, Sun Y, Liu H
and Du Z: Combinatorial microRNAs suppress hypoxia-induced
cardiomyocytes apoptosis. Cell Physiol Biochem. 37:921–932. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eide T, Taskén KA, Carlson C, Williams G,
Jahnsen T, Taskén K and Collas P: Protein kinase A-anchoring
protein AKAP95 interacts with MCM2, a regulator of DNA replication.
J Biol Chem. 278:26750–26756. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kubota S, Morii M, Yuki R and Yamaguchi N,
Yamaguchi H, Aoyama K, Kuga T, Tomonaga T and Yamaguchi N: Role for
tyrosine phosphorylation of A-kinase anchoring protein 8 (AKAP8) in
its dissociation from chromatin and the nuclear matrix. J Biol
Chem. 290:10891–10904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nebel RA, Kirschen J, Cai J, Woo YJ,
Cherian K and Abrahams BS: Reciprocal relationship between head
size, an autism endophenotype, and gene dosage at 19p13.12 points
to AKAP8 and AKAP8L. PLoS One. 10:e01292702015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Irminger-Finger I, Leung WC, Li J,
Dubois-Dauphin M, Harb J, Feki A, Jefford CE, Soriano JV, Jaconi M,
Montesano R and Krause KH: Identification of BARD1 as mediator
between proapoptotic stress and p53-dependent apoptosis. Mol Cell.
8:1255–1266. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li M and Yu X: Function of BRCA1 in the
DNA damage response is mediated by ADP-ribosylation. Cancer Cell.
23:693–704. 2013. View Article : Google Scholar : PubMed/NCBI
|
